TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 82 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $434,759 | -7.9% | 11,529 | -7.4% | 0.00% | 0.0% |
Q2 2023 | $472,039 | +99.6% | 12,445 | +28.0% | 0.00% | – |
Q1 2023 | $236,512 | -16.3% | 9,725 | 0.0% | 0.00% | – |
Q4 2022 | $282,414 | -3.3% | 9,725 | 0.0% | 0.00% | – |
Q3 2022 | $292,000 | -19.8% | 9,725 | -3.4% | 0.00% | -100.0% |
Q2 2022 | $364,000 | -16.3% | 10,066 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $435,000 | -19.7% | 10,066 | -7.0% | 0.00% | 0.0% |
Q4 2021 | $542,000 | -21.3% | 10,823 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $689,000 | -0.3% | 10,823 | +12.7% | 0.00% | 0.0% |
Q2 2021 | $691,000 | -5.0% | 9,600 | -2.7% | 0.00% | 0.0% |
Q1 2021 | $727,000 | +0.4% | 9,863 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $724,000 | -21.6% | 9,863 | +20.4% | 0.00% | -50.0% |
Q3 2017 | $923,000 | +0.5% | 8,192 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $918,000 | -20.7% | 8,192 | -17.5% | 0.00% | 0.0% |
Q1 2017 | $1,157,000 | +15.8% | 9,925 | +4.6% | 0.00% | 0.0% |
Q4 2016 | $999,000 | – | 9,487 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 565,951 | $24,483,000 | 8.44% |
Murchinson Ltd. | 162,703 | $7,039,000 | 1.34% |
Eversept Partners, LP | 220,286 | $9,529,572 | 0.73% |
BRANDES INVESTMENT PARTNERS, LP | 379,322 | $16,410,000 | 0.35% |
Analyst IMS Investment Management Services Ltd. | 17,657 | $764,000 | 0.07% |
Claret Asset Management Corp | 7,279 | $315,000 | 0.06% |
ACADIAN ASSET MANAGEMENT LLC | 326,427 | $14,086,000 | 0.06% |
Renaissance Technologies | 678,300 | $29,343,000 | 0.03% |
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 191,820 | $8,298,000 | 0.03% |
ARK Investment Management | 55,566 | $2,404,000 | 0.01% |